Viking Therapeutics, Inc. (VKTX)
30.82
-0.07
(-0.23%)
USD |
NASDAQ |
May 26, 16:00
30.57
-0.25
(-0.81%)
After-Hours: 17:24
Viking Therapeutics Shareholders Equity (Quarterly) : 501.92M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.20B |
| Amgen, Inc. | 9.19B |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Altimmune, Inc. | 283.99M |
| TG Therapeutics, Inc. | 583.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 608.24M |
| Total Liabilities (Quarterly) | 106.32M |
| Current Ratio | 5.720 |
| Net Debt Paydown Yield | 0.01% |